Rheumatology International

, Volume 34, Issue 3, pp 419–422 | Cite as

Clinical symptoms in fibromyalgia are associated to overweight and lipid profile

  • Mario D. Cordero
  • Elísabet Alcocer-Gómez
  • Francisco J. Cano-García
  • Benito Sánchez-Domínguez
  • Patricia Fernández-Riejo
  • Ana M. Moreno Fernández
  • Ana Fernández-Rodríguez
  • Manuel De Miguel
Short Communication


In order to analyze the association between body mass index (BMI), lipid profile and clinical symptoms in patients with fibromyalgia, we assessed BMI levels, lipid profile and its association with clinical symptoms in 183 patients with fibromyalgia. The patients were evaluated using tender points, FIQ and Visual Analogue Scales of pain (VAS). Serum lipid profile analysis (total cholesterol, triglyceride, HDL, LDL and VLDL), and biochemical parameters were measured in the biochemistry laboratory. The BMI distribution of the nonobese, overweight and obese patients’ groups were relatively even with 37.7, 35.5 and 26.8 %, respectively, with a mean BMI of 27.3 ± 4.9. The number of tender points showed significantly positive correlation with higher BMI (P < 0.05). A total of 57.9 % of patients showed increased levels of total cholesterol, 63.4 % increased levels of LDL cholesterol and 19.9 % high levels of triglycerides. BMI, total cholesterol and triglycerides showed high association with some clinical parameters. Overweight and lipid profile could be associated with fibromyalgia symptoms. A treatment program with weight loss strategies, and control in diet and increased physical activity is advised to patients.


BMI Lipid profile Fibromyalgia 


Conflict of interest

We have not received any financial support or other benefits from commercial sources for the study. None of the authors have any financial interests that could create a potential conflict of interest.


  1. 1.
    Lawrence RC, Helmick CG, Arnett FC et al (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778–799PubMedCrossRefGoogle Scholar
  2. 2.
    Wolfe F, Smythe HA, Yunus MB et al (1990) The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172PubMedCrossRefGoogle Scholar
  3. 3.
    Pillemer SR (1994) The fibromyalgia syndrome: current research and future directions in epidemiology pathogenesis and treatment NIH conference. J Musculoskeletal Pain 2:113–115CrossRefGoogle Scholar
  4. 4.
    Neumann L, Lerner E, Glazer Y et al (2008) A cross-sectional study of the relationship between body mass index and clinical characteristics, tenderness measures, quality of life, and physical functioning in fibromyalgia patients. Clin Rheumatol 27:1543–1547PubMedCrossRefGoogle Scholar
  5. 5.
    Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L (2007) An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 8:27PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Arranz L, Canela MA, Rafecas M (2011) Relationship between body mass index, fat mass and lean mass with SF-36 quality of life scores in a group of fibromyalgia patients. Rheumatol Int. doi: 10.1007/s00296-011-2250-y Google Scholar
  7. 7.
    Yunus MB, Arslan S, Aldag JC (2002) Relationship between body mass index and fibromyalgia features. Scand J Rheumatol 31:27–31PubMedCrossRefGoogle Scholar
  8. 8.
    Mengshoel AM, Haugen M (2001) Health status in fibromyalgia a followup study. J Rheumatol 28:2085–2089PubMedGoogle Scholar
  9. 9.
    Loevinger BL, Muller D, Alonso C, Coe CL (2007) Metabolic syndrome in women with chronic pain. Metabolism 56:87–93PubMedCrossRefGoogle Scholar
  10. 10.
    Gurer G, Sendur OF, Ay C (2006) Serum lipid profile in fibromyalgia women. Clin Rheumatol 25:300–303PubMedCrossRefGoogle Scholar
  11. 11.
    Ozgocmen S, Ardicoglu O (2000) Lipid profile in patients with fibromyalgia and myofascial pain syndromes. Yonsei Med J 41:541–545PubMedGoogle Scholar
  12. 12.
    Morris SJ, Wasko MC, Antohe JL et al (2011) Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 63:530–534CrossRefGoogle Scholar
  13. 13.
    Mok CC, Ko GT, Ho LY et al (2011) Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res (Hoboken) 63:195–202CrossRefGoogle Scholar
  14. 14.
    Obesity: preventing and managing the global epidemic (2000). Report of a WHO consultation. World Health Organ Tech Rep Ser 894:1–12, 1–253Google Scholar
  15. 15.
    Bingfors K, Isacson D (2004) Epidemiology, co-morbidity, and impact on health-related quality of life of self-reported headache and musculoskeletal pain—a gender perspective. Eur J Pain 8:435–450CrossRefGoogle Scholar
  16. 16.
    US Census Bureau: United States Census 2000. http://www.census.gov/main/www/cen2000.html (Electronic Citation2000)
  17. 17.
    Okifuji A, Bradshaw DH, Olson C (2009) Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions. Clin Rheumatol 28:475–478PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Okifuji A, Donaldson GW, Barck L, Fine PG (2010) Relationship between fibromyalgia and obesity in pain, function, mood, and sleep. J Pain 11:1329–1337PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Saggini A, Anogeianaki A, Maccauro G et al (2011) Cholesterol, cytokines and diseases. Int J Immunopathol Pharmacol 24:567–581PubMedGoogle Scholar
  20. 20.
    Klemp P, Halland AM, Majoos FL, Steyn K (1993) Musculoskeletal manifestations in hyperlipidaemia: a controlled study. Ann Rheum Dis 52:44–48PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Mario D. Cordero
    • 1
    • 2
  • Elísabet Alcocer-Gómez
    • 1
  • Francisco J. Cano-García
    • 3
  • Benito Sánchez-Domínguez
    • 4
  • Patricia Fernández-Riejo
    • 5
  • Ana M. Moreno Fernández
    • 1
  • Ana Fernández-Rodríguez
    • 1
  • Manuel De Miguel
    • 1
  1. 1.Dpto. Citología e Histología Normal y Patológica, Facultad de MedicinaUniversidad de SevillaSevillaSpain
  2. 2.Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)ISCIIISevillaSpain
  3. 3.Dpto. de Personalidad, Evaluación y Tratamiento Psicológicos, Facultad de PsicologíaUniversidad de SevillaSevillaSpain
  4. 4.Department of Periodontology, Dental SchoolUniversity of SevillaSevillaSpain
  5. 5.Dpto. de Bioquímica Clínica, Hospital Universitario Virgen Macarena. Facultad de MedicinaUniversidad de SevillaSevillaSpain

Personalised recommendations